Crista Huff

Welcome to John Ransom's Stocks In The News, where the headline meets the trendline.

Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC. Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis.            

Stock number one is:

Valeant Pharmaceuticals and Actavis Inc., (SYMBOL: VRX, ACT) and the headline says:  Merger of drugmakers Valeant, Actavis on hold  (Reuters)

Talks of a $13 billion acquisition of Actavis Inc. by Valeant Pharmaceuticals are currently on hold as both sides spar over pricing.        

Valeant is a rapidly growing specialty drugmaker, in the areas of dermatology, neurology and ophthalmology.  Valeant’s earnings are expected to grow 24% this year, and the PE is 13.6.      

Actavis develops and markets generic and branded pharmaceutical products.  Its earnings are projected to grow 35% this year, then slow dramatically thereafter.  The PE is 12.9.  Based on earnings growth and chart patterns, …        

Our Ransom Note trendline says:  BUY VALEANT PHARMACEUTICALS and HOLD ACTAVIS.

VRX Chart

VRX data by YCharts

Stock number two is:   

Gilead Sciences Inc. and Bristol-Myers Squibb Co., (SYMBOL: BMY, GILD) and the headline says: Gilead-Bristol Hepatitis C Drug Combo Cures All in Study (Bloomberg)       


Crista Huff

Crista Huff is a retired stockbroker from a NYSE member investment firm. She writes about market-timing at Goodfellow LLC and is active politically.
 
TOWNHALL DAILY: Be the first to read Crista Huff's column. Sign up today and receive Townhall.com daily lineup delivered each morning to your inbox. Release of Liability: Through use of this website viewing or using you agree to hold www.GoodfellowLLC.com and its employees harmless and to completely release www.GoodfellowLLC.com and its employees from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Goodfellow LLC and its employees are not paid by third parties to promote nor disparage any investment. Recommendations are based on hypothetical situations of what we would do, not advice on what you should do. Neither Goodfellow LLC nor its employees are licensed investment advisors, tax advisors, nor attorneys. Consult with a licensed investment advisor and a tax advisor to determine the suitability of any investment.